Pathogenesis of Cerebral Malaria: New Trends and Insights for Developing Adjunctive Therapies
No specific or adjunctive therapies exist to treat cerebral malaria (CM) as of date. CM is a neuropathological manifestation of the malaria infection in humans, caused by the hemoparasitic pathogen <i>Plasmodium falciparum</i>. Driven through a multitude of virulence factors, varied immu...
Main Authors: | Praveen Kishore Sahu, Sanjib Mohanty |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/12/4/522 |
Similar Items
-
Adjunctive therapy for severe malaria: a review and critical appraisal
by: Rosauro Varo, et al.
Published: (2018-01-01) -
Adjunctive rosiglitazone treatment for severe pediatric malaria: A randomized placebo-controlled trial in Mozambican children
by: Rosauro Varo, et al.
Published: (2024-02-01) -
Exploring adjunctive therapies for cerebral malaria
by: Johanna Bensalel, et al.
Published: (2024-02-01) -
A study on the pathogenesis of human cerebral malaria and cerebral babesiosis
by: Masamichi Aikawa, et al.
Published: (1992-01-01) -
Cytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adults
by: Yakhya Dieye, et al.
Published: (2016-05-01)